Related references
Note: Only part of the references are listed.Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations
Susan Price et al.
BLOOD (2014)
A novel homozygous Fas ligand mutation leads to early protein truncation, abrogation of death receptor and reverse signaling and a severe form of the autoimmune lymphoproliferative syndrome
Schafiq Nabhani et al.
CLINICAL IMMUNOLOGY (2014)
Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation
Aude Magerus-Chatinet et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation
Benedicte Neven et al.
BLOOD (2011)
Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation
Aude Magerus-Chatinet et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop
Joao B. Oliveira et al.
BLOOD (2010)
Using biomarkers to predict the presence of FAS mutations in patients with features of the autoimmune lymphoproliferative syndrome
Iusta Caminha et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
FAS-L, IL-10, and double-negative CD4- CD8- TCR α/β+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function
Aude Magerus-Chatinet et al.
BLOOD (2009)
Concepts of activated T cell death
Dirk Brenner et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
Perforin-dependent apoptosis functionally compensates Fas deficiency in activation-induced cell death of human T lymphocytes
Veronique Mateo et al.
BLOOD (2007)
Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib
Lilia L. Bi et al.
BMC MEDICAL GENETICS (2007)
The induction of Bim expression in human T-cell blasts is dependent on nonapoptotic Fas/CD95 signaling
Alberto Bosque et al.
BLOOD (2007)
A homozygous Fas ligand gene mutation in a patient causes a new type of autoirnmune lymphoproliferative syndrome
Manuel Del-Rey et al.
BLOOD (2006)
Autoimmune lymphoproliferative syndrome with somatic Fas mutations
E Holzelova et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Share Paper
